TITLE

Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Rate of Recurrence of Oculorespiratory Syndrome Following Influenza Vaccination among Persons Previously Affected

AUTHOR(S)
Skowronski, Danuta M.; De Serres, Gaston; Scheifele, David; Russell, Margaret L.; Warrington, Richard; Davies, H. Dele; Dionne, Marc; Duval, Bernard; Kellner, James; MacDonald, Judy
PUB. DATE
October 2003
SOURCE
Clinical Infectious Diseases;10/15/2003, Vol. 37 Issue 8, p1059
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Describes the randomized, double-blind, placebo-controlled trial to assess the rate of recurrence of oculorespiratory syndrome (ORS) following influenza virus vaccination in Canada. Risk of ORS recurrence in previously affected adults; Confirmation of a complete inactivation of virus; Accounts on the number of patients with immune system impairment.
ACCESSION #
11043933

 

Related Articles

  • © A MURINE MODEL FOR ASSESSMENT OF LIVING ATTENUATED INFLUENZA A VACCINES. Wark, Margaret C.; Tannock, Gregory A.; Sutherland, Megan M.; Smith, Linda E. // Australian Journal of Experimental Biology & Medical Science;Dec1980, Vol. 58 Issue 6, p615 

    The article discusses a murine model for assessment of living attenuated influenza A vaccines. The immunity produced from respiratory infection by influenza A viruses is considered to produce more effective resistance to subsequent reinfection than that afforded by parenteral vaccination. Ts and...

  • Influenza virus vaccine.  // Reactions Weekly;12/15/2012, Issue 1432, p29 

    The article describes the case of a three-year-old girl with systemic juvenile idiopathicarthritis (sJIA) who experienced relapse of her disease after receiving influenza vaccination.

  • Vaccines. LOCKHART, CATE // Natural Solutions;May2011, Issue 134, p8 

    A letter to the editor is presented in response to the section "Ask the Doctor" published in the November 2010 issue.

  • Expression of Concern: Immune Protection Induced on Day 10 Following Administration of the 2009 A/H1N1 Pandemic Influenza Vaccine.  // PLoS ONE;May2012, Vol. 7 Issue 5, p1 

    A correction to the article "Expression of Concern: Immune Protection Induced on Day 10 Following Administration of the 2009 A/ H1N1 Pandemic Influenza Vaccine" in the 2012 issue is presented.

  • Risk for Guillain-Barré syndrome with influenza vaccination. Hess, Karl // Pharmacy Today;Oct2011, Vol. 17 Issue 10, p42 

    The article focuses on the risk of Guillain-Barré syndrome (GBS) after influenza vaccination, as well as its recurrence. It says that GBS result from vaccination because vaccines induce the immune system in producing antigen-specific antibodies through cellular immune process. Furthermore,...

  • RSV, rhinovirus coinfection increased bronchiolitis relapse risk.  // Infectious Diseases in Children;Apr2014, Vol. 27 Issue 4, p24 

    The article highlights the discovery of a "The Pediatric Infectious Disease Journal"-published study that children with respiratory syncytial virus and human rhinovirus coinfection have a higher chance of relapsing.

  • Simultaneous immunisation with influenza vaccine and pneumococcal polysaccharide vaccine in... Fletcher, T.J.; Tunnicliffe, W.S. // BMJ: British Medical Journal (International Edition);06/07/97, Vol. 314 Issue 7095, p1663 

    Discusses the effectiveness of administering simultaneous immunization with influenza vaccine and pneumococcal polysaccharide vaccine in patients with chronic respiratory disease. Examination of immunoresponsive interaction between the vaccines; Difference in clinical characteristics between...

  • 'Tis the Season to Beat the Flu.  // Healthy Years;Nov2014, Vol. 11 Issue 11, p3 

    The article focuses on the importance of getting flu vaccine during flu season months from October to May. Persons 65 years and older are believed to have higher risk of contracting the virus as immune systems have been weakened with age. Early vaccination is recommended as antibodies develop in...

  • Four Good Reasons. Hill, Susie // Metro (NZ);May2002, Issue 251, p93 

    This article presents four reasons for the vaccination against flu in New Zealand as of May 2002. Firstly, influenza can have very serious effects in the very young and very old, leading to complications such as pneumonia, bronchitis or heart failure as well as making existing conditions worse....

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics